Minimal residual disease in non-Hodgkin's lymphoma

Biomedicine and Pharmacotherapy

Volumn 50, Issue 9, 1996, Pages 451-458

  Schultze, J L ^a   Gribben, J G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Clinical assessment; Minimal residual disease; Non Hodgkin's lymphoma; PCR

Indexed keywords

GENE REARRANGEMENT; HUMAN; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029826280     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86005-2     Document Type: Article

References (36)

1. 1 Aisenberg AC, Wilkes BM, Jacobson JO. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 1988;71:969-72
2. 2 Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ. Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms. New Engl Med 1983;309:1593-9
3. 3 Aster JC, Kobayashi Y, Shiota M, Mori S, Sklar J. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 1992;141:291-9
4. H on chromosome 14 and near a transcriptional unit on 18. Cell 1985;41:899-906
5. 5 Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Ann Rev Immunol 1994;12:881-99
6. 6 Benjamin D, Magrath IT, Douglass EC, Corash LM. Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphoma: evidence of occult bone marrow involvement. Blood 1983;61:1017-19
7. 7 Berinstein NL, Reis MD, Ngan BY, Sawka CA, Jamal HH, Kuzniar B. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early stage and advanced stage follicular lymphoma. J Clin Oncol 1993;11:1344-52
8. 8 Billadeau D, Blackstadt M, Greipp P et al. Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood 1991;78:3021-9
9. 9 Cleary ML, Chao J, Wanke R, Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B cell lymphoma. Proc Natl Acad Sci USA 1984;81:593-7
10. 10 Cleary ML, Galili N, Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 1986;164:315-20
11. 11 Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci (USA) 1985;82:7439-43
12. 12 Favrot MC, Herve P. Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumors, non-Hodgkin's lymphomas and leukemias. Bone Marrow Transplant 1987;2:117-22
13. 13 Gilliland G, Perrin S, Balnchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci (USA) 1990;87:2725-9
14. 14 Gribben JG, Freedman A, Woo SD et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991;78:3275-80
15. 15 Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991;325:1525-33
16. 16 Gribben JG, Neuberg D, Barber M et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994;83:3800-7
17. 17 Gribben JG, Neuberg D, Freedman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993;81:3449-57
18. 18 Hickish TF, Purvies H, Mansi J, Soukop M, Cunningham D. Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Br J Cancer 1991;64: 1161-3
19. 19 Hu E, Trela M, Thompson J, Lowder J, Horning S, Levy R, Sklar J. Detection of B cell lymphoma in peripheral blood by DNA hybridization. Lancet 1985;ii:1092-5
20. 20 Johnson PW, Price CG, Smith T et al. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1994;12:798-805
21. 21 Lamant L, Meggetto F, Al Saati T et al. High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996;87:284-91
22. 22 Lambrechts AC, Hupkes PE, Dorssers LCJ, van't Veer MB. Clinical significance of translocation t(14;18) positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 1994;12:1541-6
23. 23 Limpens J, De JD, Van KJ et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6:2271-6
24. 24 Limpens J, Stad R, Vos C et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995;85:2528-36
25. 25 Negrin RS, Kiem HP, Schmidt WI, Blume KG, Cleary ML. Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging. Blood 1991;77:654-60
26. 26 Price CGA, Meerabux J, Murtagh S et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991;9:1527-32
27. 27 Rimokh R, Berger F, Delsol G et al. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994;83:1871-5
28. 28 Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by culture technique. Blood 1992;79:1074-80
29. 29 Shiramizu B, Magrath I. Localization of breakpoints by polymerase chain reaction in Burkitt's lymphoma with 8;14 translocations. Blood 1990;75:1848-52
30. 30 Tonegawa S. Somatic generation of antibody diversity. Nature 1983;302:575-81
31. 31 Tsujimoto Y, Finger LR, Yunis J, Norwell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984;226:1097-9
32. 32 Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Science 1985;315:340-3
33. 33 Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M. Analysis of the t(2;5) (p23;q35) translocation hy reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995;86:2321-8
34. 34 Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R. Alterations of a zinc finger-encoding gene, bcl-6, in diffuse large-cell lymphoma. Science 1993;262:747-50
35. 35 Ye BH, Rao PH, Chaganti RS, Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993;53:2732-5
36. 36 Yunis JJ, Oken MM, Kaplan ME, Theologides RR, Howe A. Distinctive chromosomal abnormalities in histological subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982;307:1231-6